Chicago – it’s the last day of the American Society of Clinical Oncology (ASCO) annual meeting. There’s been a record attendance this year with over 30,000 people coming to Chicago to hear the latest news and research on cancer treatments.
The message I am left with is the considerable hope it offers cancer patients around the well as researchers harness the latest techniques in genome sequencing and through a deeper understanding of cancer biology, develop new targets and ways of attacking this disease. Attacking the immune system (immuno-oncology) is one of the most exciting areas in cancer drug development.
I only wish other areas of biomedical research where there is an unmet need e.g. new and effective treatments for neuro-degenerative diseases such as Alzheimers, offered such hope and focused research activity.
It’s the final day of ASCO 2014 and only the diehards are left (or those who couldn’t get a plane out early). We hope you’ve enjoyed the “live” blog and our notes from the road each day.
What are we covering this morning? Subscribers can log-in to find out more.
Chicago: Welcome to ASCO 2014 (#ASCO14), and this year’s annual meeting of the American Society of Clinical Oncology (ASCO) and the world’s largest cancer conference.
It’s the Super Bowl of cancer conferences – the meeting you not only have to be at if you’re in the field, but where you want to have your data presented. The press room is truly multinational.
The weather I have to say is glorious in Chicago, it’s probably the best time of year to visit, but as anyone who has ever been to ASCO knows, it’s an all consuming meeting and you never have any chance to visit the sights, although the travel department has kindly provided a room with a view.
This year we’ll be writing daily blog posts that provide rolling coverage – as and when the opportunity presents – we’ll be updating the post with news, commentary, and the occasional picture or clip from an interview.
Today, despite being primarily a travel day, we made it to a couple of the poster highlights sessions.
Sadly, with flights, hotels and bar bills to pay, the ASCO coverage is for subscribers only. The first of our live blogs begins below. It will probably kill us to do this, but here goes…..we’re kicking off with some commentary on the poster highlights sessions.
Subscribers can log-in to read more.